Massmutual Trust CO Fsb Tarsus Pharmaceuticals, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.7 Billion
- Q2 2025
A detailed history of Massmutual Trust CO Fsb transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 180 shares of TARS stock, worth $7,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 210
14.29%
Holding current value
$7,228
Previous $10,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.3MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$133 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$131 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$105 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$100 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$98.6 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.07B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...